NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. (“Lev” or the “Company”) (OTCBB:LEVP) announced today that Joshua Schein, Ph.D., Chief Executive Officer of Lev will present at the Susquehanna 2nd Annual SIGnificant Options in Healthcare Conference 2008, being held March 4-5 at The W Hotel in New York City. Dr. Schein will present a corporate progress report, including an update on the Company’s lead product candidate, Cinryze™ (C1 inhibitor). The Lev presentation is scheduled to begin at 2:00 PM ET on Tuesday, March 4th.
